Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y)

Melanie Kahl; Annamaria Brioli; Martin Bens; Florian Perner; Anne Kresinsky; Ulf Schnetzke; Anna Hinze; Yordan Sbirkov; Sven Stengel; Giorgia Simonetti; Giovanni Martinelli; Kevin Petrie; Arthur Zelent; Frank Dietmar Böhmer; Marco Groth; Thomas Ernst; Florian H. Heidel; Sebastian Scholl; Andreas Hochhaus; Tino Schenk

ArticleOPEN ACCESS

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y)

Leukemia

DOI: 10.1038/s41375-020-0706-3

0Citations

7Readers

Get full text

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite

CITATION STYLE

APA

Kahl, M., Brioli, A., Bens, M., Perner, F., Kresinsky, A., Schnetzke, U., … Schenk, T. (2020, July 1). Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y). Leukemia. Springer Nature. https://doi.org/10.1038/s41375-020-0706-3

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y)

Abstract

Cite

Register to see more suggestions